Celgene Medical Science Liaison, Hematology Minneapolis in Iowa City, Iowa
Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.
The Medical Science Liaison (MSL) is a member of a field-based team of scientists who function as an extension of the US Medical Affairs organization. MSLs are responsible for developing and enhancing professional relationships with medical thought leaders involved in various phases of product development. MSLs provide medical information through scientific exchange in a fair-balanced manner and provide clinical/scientific support for Celgene and the Medical Affairs department at the direction of Medical Affairs management.
This is a field-based position and requires professionals with established personal and scientific creditability to interact with thought leaders and centers of excellence. The position may involve travel of more than 50%.
*Candidates must live within the territory - Minnesota, Iowa, Nebraska, North Dakota, South Dakota
Responsibilities will include:
Identify Key Opinion Leaders (KOLs), and establish and maintain scientific relationships with KOLs; connect KOLs in academic and community centers.
Develop and execute territory plans in alignment with regional and national plans of action (POAs).
Collaborate across multiple functions and within a region(s) to maximize territory opportunities
Act as primary liaison to investigators interested in developing and performing investigator initiated research
Collaborate with the Medical Affairs and Clinical organization to enhance patient enrollment in Celgene-sponsored clinical trials with site recommendations and maintaining contact with investigators participating in ongoing studies
Provide clinical presentations and information in response to unsolicited questions (as appropriate) in academic, community, and healthcare provider settings in both group and one-on-one situations
Provide scientific and clinical support about Company products to formulary committees or payors in collaboration with Market Access
Provide scientific support at medical congresses
Provide timely feedback/information on emerging clinical/scientific data and opportunities to internal teams and stakeholders
BS degree in scientific and/or medical discipline required; MD, DO, PharmD, MSN or PhD strongly preferred
Prior field experience as a Regional Medical Liaison, or Medical Science Liaison strongly preferred
3-5 years clinical or research experience in hematology or similar specialized therapeutic area
Proven ability to work independently as well as in cross-functional networks
Current working knowledge of US legal, regulatory, and compliance regulations and guidelines relevant to industry interactions with health-care professionals
Ability to partner and maintain relationships within the medical community
Excellent communication, presentation and time management skills
Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE
At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.
“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”
There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.